Gaush Meditech Statistics

Total Valuation

Gaush Meditech has a market cap or net worth of HKD 894.71 million. The enterprise value is 943.97 million.

Market Cap	894.71M
Enterprise Value	943.97M

Important Dates

The next estimated earnings date is Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	Jun 23, 2025

Share Statistics

Gaush Meditech has 146.67 million shares outstanding. The number of shares has decreased by -0.14% in one year.

Current Share Class	146.67M
Shares Outstanding	146.67M
Shares Change (YoY)	-0.14%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	44.09%
Owned by Institutions (%)	0.99%
Float	51.41M

Valuation Ratios

The trailing PE ratio is 9.17.

PE Ratio	9.17
Forward PE	n/a
PS Ratio	0.59
PB Ratio	0.53
P/TBV Ratio	2.27
P/FCF Ratio	9.03
P/OCF Ratio	7.80
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.60, with an EV/FCF ratio of 9.53.

EV / Earnings	9.60
EV / Sales	0.62
EV / EBITDA	3.60
EV / EBIT	5.36
EV / FCF	9.53

Financial Position

The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.35.

Current Ratio	2.25
Quick Ratio	1.34
Debt / Equity	0.35
Debt / EBITDA	2.24
Debt / FCF	5.93
Interest Coverage	4.51

Financial Efficiency

Return on equity (ROE) is 5.39% and return on invested capital (ROIC) is 4.60%.

Return on Equity (ROE)	5.39%
Return on Assets (ROA)	3.83%
Return on Invested Capital (ROIC)	4.60%
Return on Capital Employed (ROCE)	8.06%
Revenue Per Employee	1.72M
Profits Per Employee	111,225
Employee Count	884
Asset Turnover	0.53
Inventory Turnover	2.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.83% in the last 52 weeks. The beta is -0.15, so Gaush Meditech's price volatility has been lower than the market average.

Beta (5Y)	-0.15
52-Week Price Change	-61.83%
50-Day Moving Average	5.79
200-Day Moving Average	8.55
Relative Strength Index (RSI)	56.84
Average Volume (20 Days)	63,900

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gaush Meditech had revenue of HKD 1.52 billion and earned 98.32 million in profits. Earnings per share was 0.67.

Revenue	1.52B
Gross Profit	695.93M
Operating Income	176.20M
Pretax Income	165.25M
Net Income	98.32M
EBITDA	236.96M
EBIT	176.20M
Earnings Per Share (EPS)	0.67

Full Income Statement

Balance Sheet

The company has 552.30 million in cash and 587.67 million in debt, giving a net cash position of -35.38 million or -0.24 per share.

Cash & Cash Equivalents	552.30M
Total Debt	587.67M
Net Cash	-35.38M
Net Cash Per Share	-0.24
Equity (Book Value)	1.69B
Book Value Per Share	11.43
Working Capital	679.97M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 114.70 million and capital expenditures -15.61 million, giving a free cash flow of 99.09 million.

Operating Cash Flow	114.70M
Capital Expenditures	-15.61M
Free Cash Flow	99.09M
FCF Per Share	0.68

Full Cash Flow Statement

Margins

Gross margin is 45.78%, with operating and profit margins of 11.59% and 6.47%.

Gross Margin	45.78%
Operating Margin	11.59%
Pretax Margin	10.87%
Profit Margin	6.47%
EBITDA Margin	15.59%
EBIT Margin	11.59%
FCF Margin	6.52%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 4.92%.

Dividend Per Share	0.30
Dividend Yield	4.92%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	160.78%
Buyback Yield	0.14%
Shareholder Yield	5.10%
Earnings Yield	10.99%
FCF Yield	11.08%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gaush Meditech has an Altman Z-Score of 3.34.

Altman Z-Score	3.34
Piotroski F-Score	n/a